• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估 Wnt 信号与透析伴严重继发性甲状旁腺功能亢进患者冠状动脉钙化的关系。

Evaluation of the association of Wnt signaling with coronary artery calcification in patients on dialysis with severe secondary hyperparathyroidism.

机构信息

Division of Nephrology, Kaohsiung Veterans General Hospital, No.386, Dazhong 1st Rd., Zuoying Dist, Kaohsiung City, 81362, Taiwan.

Department of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.

出版信息

BMC Nephrol. 2019 Sep 2;20(1):345. doi: 10.1186/s12882-019-1543-3.

DOI:10.1186/s12882-019-1543-3
PMID:31477034
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6721332/
Abstract

BACKGROUND

Patients with end-stage renal disease have a higher risk of death from cardiovascular events, which can be mainly attributed to coronary artery calcification (CAC). Wnt signaling is involved in vascular development and may play a role in vascular calcification. This study aimed to evaluate CAC prevalence in patients on dialysis with severe secondary hyperparathyroidism (SHPT) and identify CAC risk factors.

METHODS

The study is a retrospective analysis of the severe hyperparathyroidism registration study that prospectively recruited patients on dialysis with severe SHPT who were candidates for parathyroidectomy, from October 2013 to May 2015. CAC and bone mineral density (BMD) were measured. Demographic and clinical data including calcium, phosphorus, alkaline phosphatase, intact parathyroid hormone, Dickkopf-related protein 1 (DKK1), and sclerostin levels were analyzed. CAC scores were reported in Agatston units (AU).

RESULTS

A total of 61 patients were included in this study. No CAC, mild CAC (<100 AU), moderate CAC (>100 AU), and severe CAC (>400 AU) were observed in 4.9%, 11.4%, 14.8%, and 68.9% of patients, respectively. DKK1 and sclerostin were not associated with CAC. In univariate analysis, CAC was significantly correlated with age, sex (male), total cholesterol, and intravenous pulse calcitriol (p<0.05). CAC was not inversely correlated with the BMD, T scores, or Z scores of the femoral neck (p>0.05). In multivariate analysis, the stepwise forward multiple linear regression revealed that CAC was associated with age, male sex and intravenous pulse calcitriol (p<0.05). Furthermore, serum sclerostin was positively correlated with the BMD of the femoral neck but negatively associated with intact parathyroid hormone (p<0.05). Serum sclerostin was significantly associated with severely low bone mass with Z-scores<-2.5 of the femoral neck, even when adjusted for serum intact parathyroid hormone, vitamin D status, dialysis pattern, sex, and DKK-1 (p<0.05).

CONCLUSIONS

The patients on dialysis with severe SHPT have a high prevalence of vascular calcification. Although the Wnt signaling pathway could play a role in hyperparathyroid bone disease, CAC may be mainly due to the treatment modality rather than the Wnt signaling pathway associated bone metabolism in patients on dialysis with severe SHPT.

摘要

背景

终末期肾病患者死于心血管事件的风险较高,这主要归因于冠状动脉钙化(CAC)。Wnt 信号通路参与血管发育,可能在血管钙化中发挥作用。本研究旨在评估透析伴严重继发性甲状旁腺功能亢进症(SHPT)患者 CAC 的患病率,并确定 CAC 的危险因素。

方法

本研究为前瞻性招募 2013 年 10 月至 2015 年 5 月行甲状旁腺切除术的透析伴严重 SHPT 候选患者的严重甲状旁腺功能亢进登记研究的回顾性分析。测量 CAC 和骨密度(BMD)。分析包括钙、磷、碱性磷酸酶、全段甲状旁腺激素、Dickkopf 相关蛋白 1(DKK1)和骨硬化蛋白水平在内的人口统计学和临床数据。CAC 评分以 Agatston 单位(AU)报告。

结果

本研究共纳入 61 例患者。分别有 4.9%、11.4%、14.8%和 68.9%的患者无 CAC、轻度 CAC(<100 AU)、中度 CAC(>100 AU)和重度 CAC(>400 AU)。DKK1 和骨硬化蛋白与 CAC 无关。在单因素分析中,CAC 与年龄、性别(男性)、总胆固醇和静脉脉冲骨化三醇显著相关(p<0.05)。CAC 与股骨颈的 BMD、T 评分或 Z 评分无负相关(p>0.05)。多因素分析中,逐步向前多元线性回归显示 CAC 与年龄、男性和静脉脉冲骨化三醇相关(p<0.05)。此外,血清骨硬化蛋白与股骨颈 BMD 呈正相关,与全段甲状旁腺激素呈负相关(p<0.05)。血清骨硬化蛋白与股骨颈 Z 评分<-2.5 的严重低骨量显著相关,即使在调整全段甲状旁腺激素、维生素 D 状态、透析模式、性别和 DKK-1 后也是如此(p<0.05)。

结论

透析伴严重 SHPT 患者的血管钙化患病率较高。尽管 Wnt 信号通路可能在甲状旁腺亢进性骨病中发挥作用,但 CAC 可能主要与透析伴严重 SHPT 患者的治疗方式而非 Wnt 信号通路相关的骨代谢有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/6721332/5de90c2c001d/12882_2019_1543_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/6721332/5de90c2c001d/12882_2019_1543_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/6721332/5de90c2c001d/12882_2019_1543_Fig1_HTML.jpg

相似文献

1
Evaluation of the association of Wnt signaling with coronary artery calcification in patients on dialysis with severe secondary hyperparathyroidism.评估 Wnt 信号与透析伴严重继发性甲状旁腺功能亢进患者冠状动脉钙化的关系。
BMC Nephrol. 2019 Sep 2;20(1):345. doi: 10.1186/s12882-019-1543-3.
2
Evaluation of the role of severe hyperparathyroidism on coronary artery calcification in dialysis patients.评估严重甲状旁腺功能亢进在透析患者冠状动脉钙化中的作用。
Clin Nephrol. 2007 Feb;67(2):89-95. doi: 10.5414/cnp67089.
3
Abdominal aortic calcification score among several vascular calcification scores of plain radiograph is the most reliable predictor of severe coronary artery calcification in dialysis patients.在普通 X 光片的几种血管钙化评分中,腹主动脉钙化评分是透析患者严重冠状动脉钙化的最可靠预测因子。
Ren Fail. 2017 Nov;39(1):729-735. doi: 10.1080/0886022X.2017.1398666.
4
Vertebral bone density associates with coronary artery calcification and is an independent predictor of poor outcome in end-stage renal disease patients.椎骨骨密度与冠状动脉钙化相关,并且是终末期肾病患者不良预后的独立预测指标。
Bone. 2016 Nov;92:50-57. doi: 10.1016/j.bone.2016.08.007. Epub 2016 Aug 9.
5
The relationship between coronary artery calcification and bone metabolic markers in maintenance hemodialysis patients.维持性血液透析患者冠状动脉钙化与骨代谢标志物的关系。
BMC Nephrol. 2023 Aug 15;24(1):238. doi: 10.1186/s12882-023-03286-z.
6
Progression of Vascular Calcification and Clinical Outcomes in Patients Receiving Maintenance Dialysis.维持性透析患者血管钙化的进展及临床转归。
JAMA Netw Open. 2023 May 1;6(5):e2310909. doi: 10.1001/jamanetworkopen.2023.10909.
7
Impact of denosumab on cardiovascular calcification in patients with secondary hyperparathyroidism undergoing dialysis: a pilot study.唑来膦酸对接受透析治疗的继发性甲状旁腺功能亢进症患者心血管钙化的影响:一项初步研究。
Osteoporos Int. 2020 Aug;31(8):1507-1516. doi: 10.1007/s00198-020-05391-3. Epub 2020 Apr 3.
8
Predictors of coronary artery calcification and its association with cardiovascular events in patients with chronic kidney disease.预测慢性肾脏病患者冠状动脉钙化及其与心血管事件的关系。
Ren Fail. 2021 Dec;43(1):1172-1179. doi: 10.1080/0886022X.2021.1953529.
9
Changes in bone mineral density after total parathyroidectomy without autotransplantation in the end-stage renal disease patients with secondary hyperparathyroidism.甲状旁腺全切除术后无自体移植治疗继发性甲状旁腺功能亢进终末期肾病患者的骨密度变化。
BMC Nephrol. 2018 Jun 15;19(1):142. doi: 10.1186/s12882-018-0934-1.
10
Deoxycholic Acid, a Metabolite of Circulating Bile Acids, and Coronary Artery Vascular Calcification in CKD.脱氧胆酸,一种循环胆汁酸的代谢物,与 CKD 患者的冠状动脉血管钙化相关。
Am J Kidney Dis. 2018 Jan;71(1):27-34. doi: 10.1053/j.ajkd.2017.06.017. Epub 2017 Aug 9.

引用本文的文献

1
Coincidence or Causality: Parathyroid Carcinoma in Chronic Kidney Disease-Case Report and Literature Review.巧合还是因果关系:慢性肾脏病中的甲状旁腺癌——病例报告及文献综述
Diagnostics (Basel). 2024 May 29;14(11):1127. doi: 10.3390/diagnostics14111127.
2
The WNT/β-catenin system in chronic kidney disease-mineral bone disorder syndrome.慢性肾脏病-矿物质和骨异常综合征中的 WNT/β-连环蛋白系统。
Int Urol Nephrol. 2023 Oct;55(10):2527-2538. doi: 10.1007/s11255-023-03569-2. Epub 2023 Mar 24.
3
Vascular Calcification Is Associated with Fetuin-A and Cortical Bone Porosity in Stone Formers.

本文引用的文献

1
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2019 ACC/AHA 心血管疾病一级预防指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南工作组的报告。
J Am Coll Cardiol. 2019 Sep 10;74(10):1376-1414. doi: 10.1016/j.jacc.2019.03.009. Epub 2019 Mar 17.
2
Endogenous Calcification Inhibitors in the Prevention of Vascular Calcification: A Consensus Statement From the COST Action EuroSoftCalcNet.内源性钙化抑制剂在预防血管钙化中的作用:欧洲软钙化网络(COST行动)共识声明
Front Cardiovasc Med. 2019 Jan 18;5:196. doi: 10.3389/fcvm.2018.00196. eCollection 2018.
3
血管钙化与结石形成者的胎球蛋白-A和皮质骨孔隙率相关。
J Pers Med. 2022 Jul 10;12(7):1120. doi: 10.3390/jpm12071120.
4
Cardiovascular Safety of Anti-Sclerostin Therapy in Chronic Kidney Disease.抗硬化蛋白疗法在慢性肾脏病中的心血管安全性
Metabolites. 2021 Nov 10;11(11):770. doi: 10.3390/metabo11110770.
5
Correlation Between Soluble Klotho and Vascular Calcification in Chronic Kidney Disease: A Meta-Analysis and Systematic Review.慢性肾脏病中可溶性klotho与血管钙化的相关性:一项Meta分析和系统评价
Front Physiol. 2021 Aug 13;12:711904. doi: 10.3389/fphys.2021.711904. eCollection 2021.
6
Gender-Related Differences in Chronic Kidney Disease-Associated Vascular Calcification Risk and Potential Risk Mediators: A Scoping Review.慢性肾脏病相关血管钙化风险及潜在风险介导因素的性别差异:一项范围综述
Healthcare (Basel). 2021 Aug 1;9(8):979. doi: 10.3390/healthcare9080979.
7
Serum Osteoprotegerin and Carotid Intima-Media Thickness Are Related to High Arterial Stiffness in Heart Failure with Reduced Ejection Fraction.血清骨保护素与颈动脉内膜中层厚度与射血分数降低的心力衰竭患者的高动脉僵硬度相关。
Diagnostics (Basel). 2021 Apr 24;11(5):764. doi: 10.3390/diagnostics11050764.
8
WNT-β-catenin signalling - a versatile player in kidney injury and repair.WNT-β-catenin 信号通路——肾脏损伤与修复中的多面手。
Nat Rev Nephrol. 2021 Mar;17(3):172-184. doi: 10.1038/s41581-020-00343-w. Epub 2020 Sep 28.
9
The Role of Sclerostin in Bone and Ectopic Calcification.骨硬化蛋白在骨骼和异位钙化中的作用。
Int J Mol Sci. 2020 Apr 30;21(9):3199. doi: 10.3390/ijms21093199.
Calcitriol Accelerates Vascular Calcification Irrespective of Vitamin K Status in a Rat Model of Chronic Kidney Disease with Hyperphosphatemia and Secondary Hyperparathyroidism.
骨化三醇加速血管钙化,而与慢性肾脏病伴高磷血症和继发甲状旁腺功能亢进症大鼠模型中的维生素 K 状态无关。
J Pharmacol Exp Ther. 2018 Sep;366(3):433-445. doi: 10.1124/jpet.117.247270. Epub 2018 Jun 14.
4
Coronary Calcification Is Reversely Related with Bone and Hair Calcium: The Relationship among Different Calcium Pools in Body.冠状动脉钙化与骨骼及毛发钙含量呈负相关:人体不同钙池之间的关系。
J Bone Metab. 2016 Nov;23(4):191-197. doi: 10.11005/jbm.2016.23.4.191. Epub 2016 Nov 30.
5
Sclerostin and DKK1: new players in renal bone and vascular disease.骨硬化蛋白和 DKK1:肾脏骨和血管疾病的新角色。
Kidney Int. 2015 Aug;88(2):235-40. doi: 10.1038/ki.2015.156. Epub 2015 Jun 17.
6
An open-label, prospective pilot clinical study of denosumab for severe hyperparathyroidism in patients with low bone mass undergoing dialysis.一项关于地诺单抗治疗接受透析的低骨量患者严重甲状旁腺功能亢进的开放标签前瞻性试点临床研究。
J Clin Endocrinol Metab. 2014 Jul;99(7):2426-32. doi: 10.1210/jc.2014-1154. Epub 2014 Mar 26.
7
High hip fracture risk in men with severe aortic calcification: MrOS study.严重主动脉钙化男性的高髋部骨折风险:MrOS研究
J Bone Miner Res. 2014 Apr;29(4):968-75. doi: 10.1002/jbmr.2085.
8
Serum dickkopf-1 level in postmenopausal females: correlation with bone mineral density and serum biochemical markers.绝经后女性血清Dickkopf-1水平:与骨密度及血清生化标志物的相关性
J Osteoporos. 2013;2013:460210. doi: 10.1155/2013/460210. Epub 2013 Jun 27.
9
WNT signaling in bone homeostasis and disease: from human mutations to treatments.WNT 信号在骨稳态和疾病中的作用:从人类突变到治疗。
Nat Med. 2013 Feb;19(2):179-92. doi: 10.1038/nm.3074. Epub 2013 Feb 6.
10
Atherosclerotic disease in type 2 diabetes is associated with an increase in sclerostin levels.2 型糖尿病患者的动脉粥样硬化疾病与骨硬化蛋白水平升高有关。
Diabetes Care. 2013 Jun;36(6):1667-74. doi: 10.2337/dc12-1691. Epub 2013 Jan 3.